MMP-2, MMP-9, and TIMP-4 and Response to Aspirin in Diabetic and Nondiabetic Patients with Stable Coronary Artery Disease: A Pilot Study

Figure 4

The comparison of MMP-2 (a), MMP-9 (b), and TIMP-4 (c) concentrations in plasma and supernatants after platelets aggregation in patients with or without diabetes mellitus (DM). Mean ± SEM. ASA: aspirin; CAD: coronary artery disease; DM: diabetes mellitus; MMP-2: matrix metalloproteinase 2; MMP-9: matrix metalloproteinase 9; TIMP-4: tissue inhibitor of MMPs; .

(a)

(b)

(c)